Skip to content

Analysis of risk factors and prognostic factors included histological status of underlying liver disease of patients undergoing curative resection or radiofrequency ablation of hepatocellular carcinoma; May hepatic steatosis correlate with the postoperative recurrence of hepatocellular carcinoma?

Analysis of risk factors and prognostic factors included histological status of underlying liver disease of patients undergoing curative resection or radiofrequency ablation of hepatocellular carcinoma; May hepatic steatosis correlate with the postoperative recurrence of hepatocellular carcinoma? - Risk and Prognostic factors included hepatic steatosis of HCC

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000000970
Enrollment
400
Registered
2008-02-01
Start date
2004-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients with Hepatocellular carcinoma(HCC) after curative treatment

Interventions

None listed

Sponsors

Department of Internal Medicine, National Hospital Organization IwakuniClinical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: a)HCC without prior treatments b)Patients underwent curative resection or radiofrequency ablation therapy(RFA) of HCC. Resection was defined as curative when the entire tumor was macroscopically removed and the surgical margin was microscopically free from tumor invasion. c)For patients with HCC the Milan criteria were applied (solitary tumor of 5 cm, or three or fewer lesions, none >3 cm without vascular invasion, or extrahepatic metastasis).

Exclusion criteria

Exclusion criteria: a)Recurred HCC b)uncontrolled other malignancies c)ruptured HCC d)Operation-related death e)Judged to be inadequate case of this clinical study for other reasons by doctors

Design outcomes

Primary

MeasureTime frame
The cumulative tumor recurrence rate in patients with HCC

Secondary

MeasureTime frame
Cumulative survival rate in patients with HCC. Risk factors of recurrence of HCC and prognostic factors(these histological findings such as liver steatosis, liver fibrosis, and inflammation, Cancer Stage, Child-Pugh,and laboratory data, etc.)

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026